Showing results (881-890 of 1,892) with videos related to
Sort By:
Pageof 190
Immunotherapy|July 5, 2023
A plain language summary on ritlecitinib treatment for adults and adolescents with alopecia areataBrett King, Xingqi Zhang, Walter Gubelin Harcha, et al.Immunotherapy|July 4, 2023
The role of lebrikizumab in the treatment of atopic dermatitis in the adult populationStuti Prajapati, Mohammad Fardos, Amar D Desai, et al.Immunotherapy|September 5, 2023
Abrocitinib for the treatment of atopic dermatitisAna Maria Lé, Melinda Gooderham, Tiago TorresImmunotherapy|September 27, 2023
Stability assessment of anti-bacterial antibodies in immunoglobulin G-depleted serum with validated immunoassaysAndrea Engelmaier, Harald A Butterweck, Alfred WeberImmunotherapy|September 4, 2023
PD-1, PD-L1, IDO, CD70 and microsatellite instability as potential targets to prevent immune evasion in sarcomasVasiliki Siozopoulou, Evelien Smits, Karen Zwaenepoel, et al.Immunotherapy|June 9, 2023
Evaluation of appendectomy as a potential risk factor for immune checkpoint inhibitor-associated enterocolitisNira A Krasnow, Donald F Chute, Ayo S Falade, et al.Immunotherapy|October 18, 2023
Infectious adverse events in patients with atopic dermatitis treated with baricitinibFlaminia Antonelli, Dalma Malvaso, Giacomo Caldarola, et al.Immunotherapy|June 20, 2023
A meta-analysis of application of PD-1/PD-L1 inhibitor-based immunotherapy in unresectable locally advanced triple-negative breast cancerWei Zhang, Yujing He, Yuning Tang, et al.Immunotherapy|June 20, 2023
Cancer immunotherapy via stem cell-derived NK cellsFatemeh Hosseini, Mohammad Ahmadvand, Roya Karimi, et al.Immunotherapy|March 10, 2026
MicroRNA prognostic markers for immune checkpoint inhibitor success in urologic cancersPanagiotis J Vlachostergios, Konstatinos Evmorfopoulos, Konstantinos Marsitopoulos, et al.Pageof 190